Expedition of Eudragit® Polymers in the Development of Novel Drug Delivery Systems
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
Eudragit® polymer has been widely used in film-coating for enhancing the quality of products over other materials (e.g., shellac or sugar). Eudragit® polymers are obtained synthetically from the esters of acrylic and methacrylic acid. For the last few years, they have shown immense potential in the formulations of conventional, pH-triggered, and novel drug delivery systems for incorporating a vast range of therapeutics including proteins, vitamins, hormones, vaccines, and genes. Different grades of Eudragit® have been used for designing and delivery of therapeutics at a specific site via the oral route, for instance, in stomach-specific delivery, intestinal delivery, colon-specific delivery, mucosal delivery. Further, these polymers have also shown their great aptitude in topical and ophthalmic delivery. Moreover, available literature evidences the promises of distinct Eudragit® polymers for efficient targeting of incorporated drugs to the site of interest. This review summarizes some potential researches that are being conducted by eminent scientists utilizing the distinct grades of Eudragit® polymers for efficient delivery of therapeutics at various sites of interest.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
---|---|
Enthalten in: |
Current drug delivery - 17(2020), 6 vom: 15., Seite 448-469 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Jain, Sunil Kumar [VerfasserIn] |
---|
Links: |
---|
Themen: |
25086-15-1 |
---|
Anmerkungen: |
Date Completed 07.05.2021 Date Revised 07.05.2021 published: Print Citation Status MEDLINE |
---|
doi: |
10.2174/1567201817666200512093639 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM309779693 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM309779693 | ||
003 | DE-627 | ||
005 | 20231225134649.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2174/1567201817666200512093639 |2 doi | |
028 | 5 | 2 | |a pubmed24n1032.xml |
035 | |a (DE-627)NLM309779693 | ||
035 | |a (NLM)32394836 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Jain, Sunil Kumar |e verfasserin |4 aut | |
245 | 1 | 0 | |a Expedition of Eudragit® Polymers in the Development of Novel Drug Delivery Systems |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 07.05.2021 | ||
500 | |a Date Revised 07.05.2021 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
520 | |a Eudragit® polymer has been widely used in film-coating for enhancing the quality of products over other materials (e.g., shellac or sugar). Eudragit® polymers are obtained synthetically from the esters of acrylic and methacrylic acid. For the last few years, they have shown immense potential in the formulations of conventional, pH-triggered, and novel drug delivery systems for incorporating a vast range of therapeutics including proteins, vitamins, hormones, vaccines, and genes. Different grades of Eudragit® have been used for designing and delivery of therapeutics at a specific site via the oral route, for instance, in stomach-specific delivery, intestinal delivery, colon-specific delivery, mucosal delivery. Further, these polymers have also shown their great aptitude in topical and ophthalmic delivery. Moreover, available literature evidences the promises of distinct Eudragit® polymers for efficient targeting of incorporated drugs to the site of interest. This review summarizes some potential researches that are being conducted by eminent scientists utilizing the distinct grades of Eudragit® polymers for efficient delivery of therapeutics at various sites of interest | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Eudragit® | |
650 | 4 | |a colon-specific | |
650 | 4 | |a drug delivery | |
650 | 4 | |a gene delivery | |
650 | 4 | |a ophthalmic | |
650 | 4 | |a stomach-specific | |
650 | 7 | |a Polymethacrylic Acids |2 NLM | |
650 | 7 | |a methylmethacrylate-methacrylic acid copolymer |2 NLM | |
650 | 7 | |a 25086-15-1 |2 NLM | |
700 | 1 | |a Jain, Akhlesh K |e verfasserin |4 aut | |
700 | 1 | |a Rajpoot, Kuldeep |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Current drug delivery |d 2004 |g 17(2020), 6 vom: 15., Seite 448-469 |w (DE-627)NLM159100232 |x 1875-5704 |7 nnns |
773 | 1 | 8 | |g volume:17 |g year:2020 |g number:6 |g day:15 |g pages:448-469 |
856 | 4 | 0 | |u http://dx.doi.org/10.2174/1567201817666200512093639 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 17 |j 2020 |e 6 |b 15 |h 448-469 |